Literature DB >> 11948964

Intermediate cells in normal and malignant prostate epithelium express c-MET: implications for prostate cancer invasion.

Geert van Leenders1, Bianca van Balken, Tilly Aalders, Christina Hulsbergen-van de Kaa, Dirk Ruiter, Jack Schalken.   

Abstract

BACKGROUND: Analysis of keratin (K) expression discriminates luminal (K18) and intermediate (K5/18) cells in prostate carcinoma, while basal (K5/14) cells are absent. Intermediate cells have been proposed as targets of malignant transformation in prostate cancer and precursors of androgen-independent tumor progression. We demonstrate localization of hepatocyte growth factor (HGF) receptor c-MET in intermediate cells in both normal and malignant prostate epithelium.
METHODS: Receptor localization was analyzed using triple staining for c-MET, K5, K14, and K18. The percentage of strongly c-MET positive cells was determined in 15 prostate cancer patients undergoing androgen-deprivation and 14 patients without neo-adjuvant treatment. Effects of HGF were investigated on prostate cancer cell line DU145.
RESULTS: c-MET expression in non-malignant epithelium was strong in intermediate cells absent in differentiated cells, and heterogeneous in basal cells. In prostate cancer, intermediate cells displayed high c-MET levels coupled with mild expression in differentiated cells. During androgen-deprivation, 7.6% of tumor cells revealed high c-MET expression compared to 1.7% without treatment (P = 0.02). Matrigel penetration of DU145 was 8.2 +/- 1.7 mm(2) after HGF stimulation compared to 3.6 +/- 2.4 mm(2) in controls (P < 0.02).
CONCLUSIONS: Intermediate cells in normal and malignant prostate epithelium express high c-MET levels, indicating that they are prone to stromal invasion in prostate carcinoma. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948964     DOI: 10.1002/pros.10073

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  20 in total

1.  Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.

Authors:  Jiaqi Mi; Erika Hooker; Steven Balog; Hong Zeng; Daniel T Johnson; Yongfeng He; Eun-Jeong Yu; Huiqing Wu; Vien Le; Dong-Hoon Lee; Joseph Aldahl; Mark L Gonzalgo; Zijie Sun
Journal:  J Biol Chem       Date:  2018-11-06       Impact factor: 5.157

2.  ARHGAP21 protein, a new partner of α-tubulin involved in cell-cell adhesion formation and essential for epithelial-mesenchymal transition.

Authors:  Karin S A Barcellos; Carolina L Bigarella; Mark V Wagner; Karla P Vieira; Mariana Lazarini; Peter R Langford; João A Machado-Neto; Steven G Call; Davis M Staley; Jarom Y Chung; Marc D Hansen; Sara T O Saad
Journal:  J Biol Chem       Date:  2012-12-12       Impact factor: 5.157

3.  Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy.

Authors:  Geert J L H van Leenders; Wesley R Gage; Jessica L Hicks; Bianca van Balken; Tilly W Aalders; Jack A Schalken; Angelo M De Marzo
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

4.  Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis.

Authors:  Shoichiro Mukai; Kenji Yorita; Koji Yamasaki; Takahiro Nagai; Toyoharu Kamibeppu; Satoru Sugie; Kazutaka Kida; Chie Onizuka; Hiromasa Tsukino; Toshio Kamimura; Toshiyuki Kamoto; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2015-04-11       Impact factor: 4.174

5.  Curcumin mediates reversion of HGF-induced epithelial-mesenchymal transition via inhibition of c-Met expression in DU145 cells.

Authors:  Hui-Jun Hu; Xiao-Long Lin; Mi-Hua Liu; Xiao-Juan Fan; Wei-Wen Zou
Journal:  Oncol Lett       Date:  2015-12-28       Impact factor: 2.967

Review 6.  Prostate cancer progression and metastasis: potential regulatory pathways for therapeutic targeting.

Authors:  Srinivas Nandana; Leland Wk Chung
Journal:  Am J Clin Exp Urol       Date:  2014-07-12

7.  Regulation of hepatocyte activator inhibitor-1 expression by androgen and oncogenic transformation in the prostate.

Authors:  Beatrice S Knudsen; Jared M Lucas; Ladan Fazli; Sarah Hawley; Seth Falcon; Ilsa M Coleman; Dan B Martin; Chang Xu; Lawrence D True; Martin E Gleave; Peter S Nelson; Gustavo E Ayala
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

8.  Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma.

Authors:  Simion Chiosea; Elena Jelezcova; Uma Chandran; Marie Acquafondata; Teresa McHale; Robert W Sobol; Rajiv Dhir
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 9.  Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.

Authors:  Murielle Mimeault; Parmender P Mehta; Ralph Hauke; Surinder K Batra
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

Review 10.  Targeting MET and vascular endothelial growth factor receptor signaling in castration-resistant prostate cancer.

Authors:  Richard J Lee; Matthew R Smith
Journal:  Cancer J       Date:  2013 Jan-Feb       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.